Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes. Keywords : ['biphasic insulin aspart treatment', 'multinational observational study', 'improve study', 'type diabete', 'indian cohort', 'baseline characteristic'] Author : S Shah 23
Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes. Keywords : ['biphasic insulin aspart treatment', 'multinational observational study', 'improve study', 'type diabete', 'indian cohort', 'baseline characteristic'] Author : S Shah 23
Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes. Keywords : ['biphasic insulin aspart treatment', 'multinational observational study', 'improve study', 'type diabete', 'indian cohort', 'baseline characteristic'] Author : S Shah 23
Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes. Keywords : ['biphasic insulin aspart treatment', 'multinational observational study', 'improve study', 'type diabete', 'indian cohort', 'baseline characteristic'] Author : S Shah 23
Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes. Keywords : ['biphasic insulin aspart treatment', 'multinational observational study', 'improve study', 'type diabete', 'indian cohort', 'baseline characteristic'] Author : S Shah 23
Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes. Keywords : ['biphasic insulin aspart treatment', 'multinational observational study', 'improve study', 'type diabete', 'indian cohort', 'baseline characteristic'] Author : S Shah 23
Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes. Keywords : ['biphasic insulin aspart treatment', 'multinational observational study', 'improve study', 'type diabete', 'indian cohort', 'baseline characteristic'] Author : S Shah 23
Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes. Keywords : ['biphasic insulin aspart treatment', 'multinational observational study', 'improve study', 'type diabete', 'indian cohort', 'baseline characteristic'] Author : S Shah 23
Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes. Keywords : ['biphasic insulin aspart treatment', 'multinational observational study', 'improve study', 'type diabete', 'indian cohort', 'baseline characteristic'] Author : S Shah 23
Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes. Keywords : ['biphasic insulin aspart treatment', 'multinational observational study', 'improve study', 'type diabete', 'indian cohort', 'baseline characteristic'] Author : S Shah 25